IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,914,820 | +102.2% | 860,400 | +212.9% | 0.02% | +7.1% |
| Q2 2023 | $1,936,000 | -67.9% | 275,000 | -72.1% | 0.01% | -46.2% |
| Q1 2023 | $6,031,218 | +206.4% | 987,106 | +220.5% | 0.03% | +30.0% |
| Q4 2022 | $1,968,120 | +105.4% | 308,000 | +208.0% | 0.02% | +150.0% |
| Q3 2022 | $958,000 | -13.2% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $1,104,000 | +165.4% | 100,000 | +300.0% | 0.01% | +33.3% |
| Q1 2022 | $416,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |